147 related articles for article (PubMed ID: 27713035)
1. In vivo fate of lipid-based nanoparticles.
Qi J; Zhuang J; Lu Y; Dong X; Zhao W; Wu W
Drug Discov Today; 2017 Jan; 22(1):166-172. PubMed ID: 27713035
[TBL] [Abstract][Full Text] [Related]
2. In Vitro and Ex Vivo Evaluations of Lipid Anti-Cancer Nanoformulations: Insights and Assessment of Bioavailability Enhancement.
Jain AS; Dhawan VV; Sarmento B; Nagarsenker MS
AAPS PharmSciTech; 2016 Jun; 17(3):553-71. PubMed ID: 27068527
[TBL] [Abstract][Full Text] [Related]
3. Lipid nanovehicles with adjustable surface properties for overcoming multiple barriers simultaneously in oral administration.
Wu L; Liu M; Shan W; Cui Y; Zhang Z; Huang Y
Int J Pharm; 2017 Mar; 520(1-2):216-227. PubMed ID: 28185960
[TBL] [Abstract][Full Text] [Related]
4. Slowing down lipolysis significantly enhances the oral absorption of intact solid lipid nanoparticles.
Yu Z; Fan W; Wang L; He H; Lv Y; Qi J; Lu Y; Wu W
Biomater Sci; 2019 Oct; 7(10):4273-4282. PubMed ID: 31407729
[TBL] [Abstract][Full Text] [Related]
5. Biological voyage of solid lipid nanoparticles: a proficient carrier in nanomedicine.
Ali H; Singh SK
Ther Deliv; 2016 Oct; 7(10):691-709. PubMed ID: 27790956
[TBL] [Abstract][Full Text] [Related]
6. Solid Lipid Nanoparticles (SLN) and Nanostructured Lipid Carriers (NLC) for pulmonary application: a review of the state of the art.
Weber S; Zimmer A; Pardeike J
Eur J Pharm Biopharm; 2014 Jan; 86(1):7-22. PubMed ID: 24007657
[TBL] [Abstract][Full Text] [Related]
7. Cationic ligand appended nanoconstructs: a prospective strategy for brain targeting.
Agarwal A; Agrawal H; Tiwari S; Jain S; Agrawal GP
Int J Pharm; 2011 Dec; 421(1):189-201. PubMed ID: 21986113
[TBL] [Abstract][Full Text] [Related]
8. Size-exclusive effect of nanostructured lipid carriers on oral drug delivery.
Li H; Chen M; Su Z; Sun M; Ping Q
Int J Pharm; 2016 Sep; 511(1):524-537. PubMed ID: 27452421
[TBL] [Abstract][Full Text] [Related]
9. Intracellular trafficking of solid lipid nanoparticles and their distribution between cells through tunneling nanotubes.
Kristl J; Plajnšek KT; Kreft ME; Janković B; Kocbek P
Eur J Pharm Sci; 2013 Sep; 50(1):139-48. PubMed ID: 23628779
[TBL] [Abstract][Full Text] [Related]
10. Influence of different surfactants on the technological properties and in vivo ocular tolerability of lipid nanoparticles.
Leonardi A; Bucolo C; Romano GL; Platania CB; Drago F; Puglisi G; Pignatello R
Int J Pharm; 2014 Aug; 470(1-2):133-40. PubMed ID: 24792979
[TBL] [Abstract][Full Text] [Related]
11. Lipid-based nanoformulations for peptide delivery.
Matougui N; Boge L; Groo AC; Umerska A; Ringstad L; Bysell H; Saulnier P
Int J Pharm; 2016 Apr; 502(1-2):80-97. PubMed ID: 26899976
[TBL] [Abstract][Full Text] [Related]
12. Nanostructured lipid carriers, solid lipid nanoparticles, and polymeric nanoparticles: which kind of drug delivery system is better for glioblastoma chemotherapy?
Qu J; Zhang L; Chen Z; Mao G; Gao Z; Lai X; Zhu X; Zhu J
Drug Deliv; 2016 Nov; 23(9):3408-3416. PubMed ID: 27181462
[TBL] [Abstract][Full Text] [Related]
13. A novel approach to enhance the mucoadhesion of lipid drug nanocarriers for improved drug delivery to the buccal mucosa.
Du JD; Liu Q; Salentinig S; Nguyen TH; Boyd BJ
Int J Pharm; 2014 Aug; 471(1-2):358-65. PubMed ID: 24879939
[TBL] [Abstract][Full Text] [Related]
14. Solid lipid nanoparticles suspension versus commercial solutions for dermal delivery of minoxidil.
Padois K; Cantiéni C; Bertholle V; Bardel C; Pirot F; Falson F
Int J Pharm; 2011 Sep; 416(1):300-4. PubMed ID: 21704140
[TBL] [Abstract][Full Text] [Related]
15. Interactions of lipid-based liquid crystalline nanoparticles with model and cell membranes.
Barauskas J; Cervin C; Jankunec M; Spandyreva M; Ribokaite K; Tiberg F; Johnsson M
Int J Pharm; 2010 May; 391(1-2):284-91. PubMed ID: 20214966
[TBL] [Abstract][Full Text] [Related]
16. Lipid-based nanocarriers for the oral administration of biopharmaceutics.
Karamanidou T; Bourganis V; Kammona O; Kiparissides C
Nanomedicine (Lond); 2016 Nov; 11(22):3009-3032. PubMed ID: 27781558
[TBL] [Abstract][Full Text] [Related]
17. Morphological observations on a lipid-based drug delivery system during in vitro digestion.
Fatouros DG; Bergenstahl B; Mullertz A
Eur J Pharm Sci; 2007 Jun; 31(2):85-94. PubMed ID: 17418543
[TBL] [Abstract][Full Text] [Related]
18. Effects of PEGylated lipid nanoparticles on the oral absorption of one BCS II drug: a mechanistic investigation.
Zhang X; Chen G; Zhang T; Ma Z; Wu B
Int J Nanomedicine; 2014; 9():5503-14. PubMed ID: 25473287
[TBL] [Abstract][Full Text] [Related]
19. Liposomally formulated phospholipid-conjugated novel near-infrared fluorescence probe for particle size effect on cellular uptake and biodistribution in vivo.
Xing J; Liu D; Zhou G; Li Y; Wang P; Hu K; Gu N; Ji M
Colloids Surf B Biointerfaces; 2018 Jan; 161():588-596. PubMed ID: 29154213
[TBL] [Abstract][Full Text] [Related]
20. Solid lipid nanoparticles: an oral bioavailability enhancer vehicle.
Harde H; Das M; Jain S
Expert Opin Drug Deliv; 2011 Nov; 8(11):1407-24. PubMed ID: 21831007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
